Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders

Detalles Bibliográficos
Autores principales: Schieber, Timothy, Li, Anthony, Lundberg, Jordan, Wiczer, Tracy, Voorhees, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345846/
https://www.ncbi.nlm.nih.gov/pubmed/36877766
http://dx.doi.org/10.1182/bloodadvances.2022009548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345846/
https://www.ncbi.nlm.nih.gov/pubmed/36877766
http://dx.doi.org/10.1182/bloodadvances.2022009548

Ejemplares similares